A diagnosis can be the beginning of a lifelong journey. Our commitment to patient support extends to our whole genome sequencing with Patient for Life™️. Proactive, continuous reanalysis of genetic data done automatically without provider requests.
- New answers, not just reclassifications – When new gene–disease associations are discovered, we proactively review all past cases so even a previous “negative” can become a new diagnosis.
- Amended reports, automatically – We continuously search in the background and update reports when new information emerges, so patients get answers without providers needing to request them.
- Post-test genetic counseling – Expert guidance to help you understand your results and any updates along the way.
Experience our commitment to lifelong support: hubs.ly/Q04B3y120
#PatientForLife #WholeGenome #PatientSupport # #FamilySupport
From research on MAVEs to secondary findings to deep intronic variants, Day 1 at #ASHG26 sparked incredible conversations at our posters.
Thank you to everyone who stopped by to connect with our team! If you missed any of today’s presentations, you can explore all our posters here: hubs.ly/Q04C1Vyh0
Join us for a live webinar on 10/29 at 11 AM PDT to learn how clinician-advocacy collaborations drive improved patient outcomes while fostering meaningful professional growth, learning, and career enrichment.
Register now: hubs.ly/Q04BM3Jm0
*This live webinar is eligible for CE credit. A recorded version will be available for CE credit on our website.
Explore how whole exome and genome sequencing help families end the diagnostic odyssey in a new white paper: hubs.ly/Q04B2XGq0
Whole Genome Sequencing provides answers where other tests cannot. In this case study, see how WGS plus RNA helped end the diagnostic odyssey for a patient with Sanfilippo Syndrome. hubs.ly/Q04zrxGq0
For Breast Cancer Awareness Month, Jewel Wasson, MS, CGC, joins the Gene Scene to discuss pathogenic variants in BRCA2, BRCA2-related cancer predisposition, and BRCA2-related Fanconi anemia. #GeneScene #GeneChat #GeneticTesting
hubs.ly/Q04zhz-t0
Whole Genome Testing is now available from Ambry. Read the press release: hubs.ly/Q04zFhLR0
COMING SOON
The Next Generation of Clinical Genome Testing
Built for more answers, more access, and more support.
October 2026
Join us for a webinar on Wednesday, October 7. Elizabeth Jordan, MMSc, CGC, will explore the evolving landscape of cardiovascular genetics in diverse populations, with a focus on how diverse representation shapes discovery, interpretation, and clinical care.
Register now: hubs.ly/Q04zmTcQ0
Brooke Sample, MS, CGC, explores pathogenic variants in the DES gene, which have been associated with a spectrum of DES-related myopathies, including dilated cardiomyopathy (DCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC), and myofibrillar myopathy (MFM). #GeneScene #GeneChat #DES #Cardio
hubs.ly/Q04zh7Vt0
Thank you for joining Ambry in recognizing National Hereditary Cancer Week. You can use the hashtag #NHCW2026 to share your story. Visit the Ambry website to learn more about hereditary cancer testing options. For more resources, click here for a cultivated list from Marleah Dean Kruzel, PhD.
hubs.ly/Q04z2Kj40
#Previvor #HereditaryCancer #GeneChat #DigitalHealth #BRCA #LynchSyndrome
As we recognize National Hereditary Cancer Week, we present these "Myth-busters" to debunk common misconceptions about hereditary cancer testing (HCT).
#NHCW2026 #HereditaryCancer #GeneChat #GeneticTesting
Join Ambry at the American Academy of Pediatrics (AAP) Annual Meeting October 3-5 in San Diego. For families looking for answers, genetic testing and proactive reanalysis can help end the diagnostic odyssey. Visit our booth or meet with one of our representatives to explore how we are advancing clinical genomics for children with intellectual disability and global developmental delay. Learn more or request a meeting. hubs.ly/Q04yMkbY0 #AAP2026 #genetictesting #raredisease
It’s important to discuss health history with family members. But even when you get a relevant test result, life can get in the way. Marleah continues illuminating the path of her previvor journey. hubs.ly/Q04yXzhb0
Marleah Dean Kruzel, PhD, joined us to recognize National Previvor Day by sharing her personal "Journey to Previvorship." She uses her unique perspective as a BRCA2 previvor to empower others who carry a genetic predisposition to cancer. Watch the video and click to learn more. hubs.ly/Q04yJxFl0
hubs.ly/Q04yJxCz0
#NHCW2026 #Previvor #HereditaryCancer #GeneChat #breastcancer #Oncology #Healthcare #NarrativeMedicine #GeneticTesting #BRCA #LynchSyndrome
At Ambry, we are passionate about offering genetic testing that provides patients with information to inform their healthcare journey.
Inherited gene mutations account for 5-10% of all cancers. Many individuals with an inherited mutation remain unaware of their risk and available medical options.
How do you know if you should get genetic testing? This page explains how to talk to your healthcare provider and determine your risk. Learn more: hubs.ly/Q04yyRzT0
